Quoin Pharmaceuticals (QNRX)

• Market cap: $5.44M
• 1 day: 5.13%
• 5 days: -19.7%
• 1 month: 15.51%
• 3 months: 30.39%
• 6 months: 46.98%
• Year to date: -61.66%
• 1 year: -62.85%
• 5 years: -99.98%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3